Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frans Rutten

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
International Journal of Technology Assessment in Health Care|June 5, 2004
Health technology assessment and policy from the economic perspectiveFrans Rutten
Pharmacoeconomics|January 22, 2005
The impact of healthcare reform in the NetherlandsFrans Rutten
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 8, 2005
Practice guidelines based on clinical and economic evidence. Indispensable tools in future market oriented health careFrans Rutten, Werner Brouwer, Louis Niessen
Pharmacoeconomics|September 18, 2003
Cost-effectiveness league tables: valuable guidance for decision makers?Josephine Mauskopf, Frans Rutten, Warren Schonfeld
Pharmacoeconomics|September 19, 2002
Combining a budgetary-impact analysis and a cost-effectiveness analysis using decision-analytic modelling techniquesMark J C Nuijten, Frans Rutten
Pharmacoeconomics|April 27, 2013
Productivity costs in economic evaluations: past, present, futureMarieke Krol, Werner Brouwer, Frans Rutten
Pharmacoeconomics|September 10, 2003
The incorporation of potential confounding variables in Markov modelsMark J C Nuijten, Frans Rutten
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
Cost-Effectiveness and Dynamic Efficiency: Does the Solution Lie Within?Rodrigo Refoios Camejo, Marisa Miraldo, Frans Rutten
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 31, 2010
Reimbursement of pharmaceuticals: reference pricing versus health technology assessmentMichael Drummond, Bengt Jönsson, Frans Rutten, et al.
Pharmacoeconomics|April 11, 2013
The determinants of cost-effectiveness potential: an historical perspective on lipid-lowering therapiesRodrigo Refoios Camejo, Clare McGrath, Marisa Miraldo, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Technology Assessment in Health Care|June 5, 2004
Health technology assessment and policy from the economic perspectiveFrans Rutten
Pharmacoeconomics|January 22, 2005
The impact of healthcare reform in the NetherlandsFrans Rutten
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 8, 2005
Practice guidelines based on clinical and economic evidence. Indispensable tools in future market oriented health careFrans Rutten, Werner Brouwer, Louis Niessen
Pharmacoeconomics|September 18, 2003
Cost-effectiveness league tables: valuable guidance for decision makers?Josephine Mauskopf, Frans Rutten, Warren Schonfeld
Pharmacoeconomics|September 19, 2002
Combining a budgetary-impact analysis and a cost-effectiveness analysis using decision-analytic modelling techniquesMark J C Nuijten, Frans Rutten
Pharmacoeconomics|April 27, 2013
Productivity costs in economic evaluations: past, present, futureMarieke Krol, Werner Brouwer, Frans Rutten
Pharmacoeconomics|September 10, 2003
The incorporation of potential confounding variables in Markov modelsMark J C Nuijten, Frans Rutten
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|February 27, 2017
Cost-Effectiveness and Dynamic Efficiency: Does the Solution Lie Within?Rodrigo Refoios Camejo, Marisa Miraldo, Frans Rutten
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|August 31, 2010
Reimbursement of pharmaceuticals: reference pricing versus health technology assessmentMichael Drummond, Bengt Jönsson, Frans Rutten, et al.
Pharmacoeconomics|April 11, 2013
The determinants of cost-effectiveness potential: an historical perspective on lipid-lowering therapiesRodrigo Refoios Camejo, Clare McGrath, Marisa Miraldo, et al.
Pageof 5